EFPIA, SIFFA and Latvian government meet to boost patient access to medicines

28 September 2015

Last week, senior representatives of the pharmaceutical industry, including Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Imants Sinka and Dita-Erna Sile, respectively chairman and director general of the Latvian Association of International Research-based Pharmaceutical Manufacturers (SIFFA), met in Riga with Latvian Minister of Health Guntis Belēvičs.

The purpose of the meeting is to kick-start the implementation of the proposals contained within the Letter of Intent, signed between the Latvian government and the pharmaceutical industry on June 29 this year. The principal signatories to the Letter of Intent include EFPIA, SIFFA and the Ministry of Health, as well as the Academy of Science.

Aim to facilitate stable and predictable business conditions

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK